Equities

Health Sciences Acquisitions Corp 2

HSAQ:NAQ

Health Sciences Acquisitions Corp 2

Actions
FinancialsOpen End and Miscellaneous Investment Vehicles
  • Price (USD)9.90
  • Today's Change0.00 / 0.00%
  • Shares traded2.71k
  • 1 Year change+0.10%
  • Beta--
Data delayed at least 15 minutes, as of Sep 30 2022 20:59 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Health Sciences Acquisitions Corporation 2 is a blank check company. The Company was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses. It intends to target companies domiciled in North America or Europe that are developing assets in the biopharma and medical technology sectors. It has generated no revenues.

  • Revenue in USD (TTM)0.00
  • Net income in USD-1.35m
  • Incorporated2020
  • Employees--
  • Location
    Health Sciences Acquisitions Corp 2412 West 15Th Street, Floor 9NEW YORK 10011United StatesUSA
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
HSAQ:NAQ since
announced
Transaction
value
Orchestra BioMed IncAnnounced05 Jul 202205 Jul 2022Announced-0.80%93.00m
Data delayed at least 15 minutes, as of Sep 30 2022 20:59 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
AG Mortgage Investment Trust Inc117.14m-34.83m108.69m0.00--0.4207--0.9278-0.8226-0.82265.6721.280.0387--2.12---0.4265-1.02-0.656-3.6341.5046.95-11.01-27.25--1.120.8756---5.18-10.49119.9011.33---28.70
Better World Acquisition Corp0.003.93m108.87m0.0040.291.58----0.25690.25690.006.570.00------3.90--3.94--------------0.027------150.15------
Grayscale Ethereum Classic Trust (Etc)0.00-512.66m108.87m----0.6262-----36.64-36.640.0012.43---------------------------0.02880.00------4,900.69------
Permianville Royalty Trust10.77m8.68m108.90m0.0012.551.73--10.110.2630.2630.32651.900.1646------13.2618.5913.3418.60----80.5594.64----0.00100.00-21.75-13.92-37.92-18.14---6.53
Denali Capital Acquisition Corp-100.00bn-100.00bn109.20m----1.32----------7.62----------------------------0.00--------------
Western Asset Municipal Partners Fnd Inc8.12m-19.30m109.34m----0.7746--13.46-1.99-1.990.835616.410.0331-------7.843.65-8.013.6874.6078.04-237.0197.21--0.22510.297974.50-4.10-3.6930.45-----8.11
Nuveen Select Maturities Municipal Fund-100.00bn-100.00bn110.77m--------------------------------------------------------------
8i Acquisition 2 Corp-100.00bn-100.00bn110.96m----1.30----------7.69----------------------------0.0097-------20,936.28------
Health Sciences Acquisitions Corp 20.00-1.35m111.11m----1.31-----0.0661-0.06610.007.570.00-------0.835---0.8383--------------0.00-------118.25------
Alset Capital Acquisition Corp-100.00bn-100.00bn111.20m----1.30----------7.61----------------------------0.00--------------
Genesis Unicorn Capital Corp-100.00bn-100.00bn111.68m----1.31----------7.62----------------------------0.00--------------
Flahrty & Crmrn Pref and Incm Opp Fd Inc-100.00bn-100.00bn111.83m0.00------------------------------------------------------------
Broad Capital Acquisition Corp-100.00bn-100.00bn112.34m----1.32----------7.58----------------------------0.00--------------
AIB Acquisition Corp-100.00bn-100.00bn112.97m----1.34----------7.52----------------------------0.00--------------
Counter Press Acquisition Corp-100.00bn-100.00bn113.71m----1.33----------7.58----------------------------0.00--------------
Data as of Sep 30 2022. Currency figures normalised to Health Sciences Acquisitions Corp 2's reporting currency: US Dollar USD

Institutional shareholders

31.58%Per cent of shares held by top holders
HolderShares% Held
D. E. Shaw & Co. LPas of 30 Jun 2022938.39k4.59%
Adage Capital Management LPas of 30 Jun 2022800.00k3.91%
Saba Capital Management LPas of 30 Jun 2022737.49k3.61%
T. Rowe Price Associates, Inc. (Investment Management)as of 30 Jun 2022727.20k3.56%
RA Capital Management LPas of 30 Jun 2022625.00k3.06%
Amitell Capital Pte Ltd.as of 30 Jun 2022600.14k2.94%
Sculptor Capital LPas of 30 Jun 2022542.85k2.66%
BlackRock Advisors LLCas of 30 Jun 2022509.35k2.49%
W.R. Berkley Corp. (Investment Portfolio)as of 30 Jun 2022492.21k2.41%
Centiva Capital LPas of 30 Jun 2022484.33k2.37%
More ▼
Data from 30 Jun 2022 - 30 Jun 2022Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.